GlassScriptPhysician profile
Daniel Alexander King
NPI 1801281894
$19,474.86
in general payments reported to CMS, 2019-2025
9 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,095 · 2022: $32.63 · 2023: $378 · 2024: $5,782 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,710 · Consulting Fee: $5,675 · Travel and Lodging: $1,914 · Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,710.00 |
| Consulting Fee | $5,675.00 |
| Travel and Lodging | $1,913.94 |
| Food and Beverage | $1,048.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $8,731.42 | 2021-2025 | Onivyde |
| Partner Therapeutics, INC. | $4,295.04 | 2025 | Bizengri, Leukine, Bizengri |
| Histosonics, INC. | $2,150.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $2,012.79 | 2023-2025 | Imfinzi |
| Astrazeneca Uk Limited | $2,010.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $174.96 | 2022-2023 | |
| Trisalus Life Sciences, INC. | $100.65 | 2023 | Trinav Infusion System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.